Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Hair restoration surgery effectively treats hair loss with natural-looking results, using techniques like stem cells and platelet-rich plasma.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Finasteride may cause cataracts and floppy-iris syndrome.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride causes lasting fertility decrease in rats.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Treat pattern hair loss with finasteride and topical minoxidil.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

Some nonsurgical hair loss treatments are effective, especially if started early.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Negative expectations can cause adverse effects in dermatology treatments, like with finasteride for baldness, and careful communication can help reduce these nocebo responses.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

LLLT is a safe, promising hair loss treatment, but more research needed.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

BeauTop improves hair growth in androgenetic alopecia patients.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.